Literature DB >> 18245943

Persistent thrombocytopenia following dengue shock syndrome.

Utkarsh Kohli1, Sunil Saharan, Rakesh Lodha, S K Kabra.   

Abstract

Though thrombocytopenia is one of the hallmarks of dengue hemorrhagic fever/ dengue shock syndrome, persistence of the same is rare. We report an 11 year-old child with dengue shock syndrome, who developed persistent thrombocytopenia. The possible mechanisms are discussed.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18245943      PMCID： PMC7101604          DOI： 10.1007/s12098-008-0014-9

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


  9 in total

1.  Clinical profile and outcome of Dengue fever cases.

Authors:  Vinod H Ratageri; T A Shepur; P K Wari; S C Chavan; I B Mujahid; P N Yergolkar
Journal:  Indian J Pediatr       Date:  2005-08       Impact factor: 1.967

Review 2.  Thrombocytopenia in dengue fever.

Authors:  Katherine I Schexneider; Edward A Reedy
Journal:  Curr Hematol Rep       Date:  2005-03

3.  Corticosteroid-responsive prolonged thrombocytopenia following dengue haemorrhagic fever.

Authors:  K W Leong; P Srinivas
Journal:  Med J Malaysia       Date:  1993-09

4.  Dengue virus and endothelial cell: a related phenomenon to thrombocytopenia and granulocytopenia in dengue hemorrhagic fever.

Authors:  P Butthep; A Bunyaratvej; N Bhamarapravati
Journal:  Southeast Asian J Trop Med Public Health       Date:  1993       Impact factor: 0.267

5.  Dengue haemorrhagic fever with unusual prolonged thrombocytopaenia.

Authors:  S M Kamil; N H Mohamad; M Y Narazah; F A Khan
Journal:  Singapore Med J       Date:  2006-04       Impact factor: 1.858

6.  Association of increased platelet-associated immunoglobulins with thrombocytopenia and the severity of disease in secondary dengue virus infections.

Authors:  M Saito; K Oishi; S Inoue; E M Dimaano; M T P Alera; A M P Robles; B D Estrella; A Kumatori; K Moji; M T Alonzo; C C Buerano; R R Matias; K Morita; F F Natividad; T Nagatake
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

Review 7.  Mechanisms of dengue virus-induced bone marrow suppression.

Authors:  V F La Russa; B L Innis
Journal:  Baillieres Clin Haematol       Date:  1995-03

8.  Dengue and dengue haemorrhagic fever.

Authors:  J G Rigau-Pérez; G G Clark; D J Gubler; P Reiter; E J Sanders; A V Vorndam
Journal:  Lancet       Date:  1998-09-19       Impact factor: 79.321

9.  The use of intravenous gammaglobulin in dengue fever, a case report.

Authors:  D P Ascher; H F Laws; C G Hayes
Journal:  Southeast Asian J Trop Med Public Health       Date:  1989-12       Impact factor: 0.267
  9 in total
  6 in total

1.  Persistent thrombocytopenia following dengue shock syndrome.

Authors:  Syed Ahmed Zaki; Preeti Shanbag
Journal:  Indian J Pediatr       Date:  2009-06       Impact factor: 1.967

2.  Intravenous immunoglobulin for severe thrombocytopenia in secondary dengue.

Authors:  Vinod Kumar; Kartik Gupta; Manish Soneja; Ashutosh Biswas
Journal:  BMJ Case Rep       Date:  2018-06-27

3.  Dengue hemorrhagic fever as a rare cause of chronic immune thrombocytopenic purpura-a pediatric case report.

Authors:  V Thadchanamoorthy; Kavinda Dayasiri
Journal:  Trop Med Health       Date:  2020-07-20

4.  Intravenous Immunoglobulin Responsive Persistent Thrombocytopenia after Dengue Haemorrhagic Fever.

Authors:  Prabhat Kumar; Riyaz Charaniya; Anindya Ghosh; Ratnakar Sahoo
Journal:  J Clin Diagn Res       Date:  2016-04-01

5.  Prospective study of patients with persistent symptoms of dengue in Brazil.

Authors:  Luciana de Almeida Silva Teixeira; Fabiana Prado Dos Santos Nogueira; Gabriel Antonio Nogueira Nascentes
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2017-09-04       Impact factor: 1.846

6.  Dengue, HIV and thrombocytopenia.

Authors:  Pankaj Garg; Suranjith L Seneviratne
Journal:  Indian J Pediatr       Date:  2008-11       Impact factor: 1.967
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.